0

US Mobile Cardiac Telemetry Devices Market: Current Analysis and Forecast (2021-2027)

Region:North America

Author(s):

Product Code:UMHE21309

Download Sample Report download
Buy the Full ReportStarting from $2800
Published on

July 2021

Total pages

112

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2800

About the Report

About the Report

Mobile Cardiac Telemetry (MCT) technology allows the monitoring of the patient over 24 hours due to its compact design. Heart disease is one of the leading causes of death globally. More than 46% of US adults are estimated to suffer from hypertension.

The rising worldwide demand for United States Mobile Cardiac Telemetry Devices systems is because of the increasing prevalence of cardiovascular disorders, associated mortality has increased awareness about the benefits, and upsurge in venture capital investments. For instance, the medical technology venture capital investment all over the world was valued at 5.7 billion U.S. dollars in 2019 which rose to 6.3 billion U.S. dollars in 2020. In addition to this, the largest increase in the MedTech venture capital investment was seen during the years 2016 and 2017.

The growing prevalence of heart valve disease coupled with the rising geriatric population is another factor contributing to the growth of the United States Mobile Cardiac Telemetry Devices systems market. For instance, according to the United Nations, In 2019, 13.2% of the worldwide population was aged 60 years or above. Further, it is anticipated that nearly 21.4% of the total worldwide population will be aged 60 years or over by 2050. Given these facts, there is an increase in the number of people who are not suitable for open-heart surgeries. As a result, there is an increase in the adoption of minimally invasive surgical procedures such as United States Mobile Cardiac Telemetry Devices procedures augmenting the growth of the United States Mobile Cardiac Telemetry Devices market globally.

However, some of the restraints in the market include clinical effectiveness, high cost and data infringement associated with the mobile cardiac telemetry devices are impeding the growth of this market all over the world. Based on technology, the market is divided into lead-based and patch-based. The lead-based segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027. However, patch-based devices are anticipated to grow by the highest CAGR.
 
Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, and home settings. The hospitals' segment grabbed XX% market share of the United States Mobile Cardiac Telemetry Devices market and gathered revenue of USD XX million in 2020. However, the home setting is expected to witness the highest CAGR of XX% during the forecast period.

For a better understanding of the market adoption of United States Mobile Cardiac Telemetry Devices procedures, the market is analyzed based on its worldwide presence in the countries such as Mid-West United States, South United States, North-East United States, and the West United States and Rest of World. North-East United States constitutes the largest market for the United States Mobile Cardiac Telemetry Devices industry and generated revenue of USD XX million in 2020 owing to the government support for advanced research and increasing awareness regarding the benefits offered by Mobile Cardiac Telemetry Devices.

Some of the major players operating in the market include BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp, Preventice Solution; etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

The United States Mobile Cardiac Telemetry Devices market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021 to 2027F. The United States Mobile Cardiac Telemetry Devices market is expected to witness a boost on account of the increasing demand for United States Mobile Cardiac Telemetry Devices systems due to the surge in the 24-hour monitoring devices and the growing aging population. In addition to this, key players worldwide are introducing new products to cater to the middle-income group propelling the growth of the United States Mobile Cardiac Telemetry Devices market.

Products


Companies

BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp, and Preventice Solution

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the US Mobile Cardiac Telemetry Devices Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the US Mobile Cardiac Telemetry Devices Market

2.1.1 Main Objective of the US Mobile Cardiac Telemetry Devices Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER MOBILE CARDIAC TELEMETRY DEVICES INDUSTRY

6 COVID-19 IMPACT

7 UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET REVENUE

8 MARKET INSIGHTS BY TECHNOLOGY

8.1 Lead-Based

8.2 Patch-Based

9 MARKET INSIGHTS BY END-USER

9.1 Hospitals

9.2 Ambulatory Surgical Centres

9.3 Home settings

11 MARKET INSIGHTS BY REGION

11.1 MID-WEST UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET

11.2 SOUTH UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET

11.3 NORTH-EAST UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET

11.4 WEST UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET

12 US MOBILE CARDIAC TELEMETRY DEVICES MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 US MOBILE CARDIAC TELEMETRY DEVICES MARKET OPPORTUNITIES

17 US MOBILE CARDIAC TELEMETRY DEVICES MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Koninklijke Philips N.V.

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Koninklijke Philips N.V.

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 BioTelemetry Inc.

19.3 Biotricity

19.4 Comarch

19.5 Hill-Rom Holdings Inc.

19.6 Infobionic

19.7 Medicalgorithmics

19.8 Medicomp

19.9 Preventice Solution

20 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022